B. Fauroux (Paris, France), H. Grasemann (Essen, Germany)
A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations
A. Bassotti, M. Seia, C. Corbetta, A. Giunta, R. Padoan (Milano, Italy)
|  |
Impact of developing an outreach educational programme for improving on the physician's ability to make the diagnosis of cystic fibrosis
L. L. Dracea, O. Falup-Pecurariu, D. Voda, S. Buzinschi (Brasov, Romania)
| |
Comparative evaluation of mucociliary clearance in patients with mucoviscedosis and chronic obstructive bronchitis and one influence of hypertonic sodium chloride concentrations on it
V. Kobylyansky (Saint-Petersburg, Russia)
| |
Function of ciliary epithelium in the patients with cystic fibrosis (CF) with chronic Ps.aeruginosa infection and without Ps.aeruginosa
A. G. Tchermensky, T. E. Gembitskaya, L. F. Kovaleva, T. S. Sologub, M. E. Faustova (Saint-Petersburg, Russia)
| |
Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients
E. N. Mitkina, T. E. Gembitskaia, L. A. Jelenina, M. A. Zaitseva, A. G. Tchermenski (Saint-Petersburg, Russia)
| |
Response to isoprenaline at nasal potential difference measurement and clinical variability in ΔF508 homozygote Cystic Fibrosis patients
L. Romano, R. Casciaro, I. Negro, N. Minuto, L. J. Galietta, O. Zegarra-Moran (Genova, Italy)
| |
Cytokine production in whole blood and disease severity in cystic fibrosis
S. Schmitt-Grohe, C. Naujoks, R. Schubert, J. Bargon, T. O. Wagner, S. Zielen (Bonn, Frankfurt, Germany)
| |
Cystic fibrosis patients were incapable of excessive IL-10 production in response to antigen challenge
G. V. Shmarina, A. L. Pukhalsky, L. A. Shabalova, S. N. Kokarovtseva, M. S. Blakher (Moscow, Russia)
| |
The role of disbalance in the system of neutrophil/elastase and alpha1-antiprotease in the course of respiratory infectious process in CF
L. A. Jelenina, E. K. Dotzenko, V. A. Goncharova, T. S. Sologub, T. E. Gembitskaia (Saint-Petersburg, Russia)
| |
Myeloperoxidase and lactoferrin in serum of children with exacerbation of cystic fibrosis
T. Bulgakova, E. Surkova, T. Ses, G. Aleshina, T. Sologub, E. Boitsova, T. Gembitskaia (Saint-Petersburg, Russia)
| |
Immunoregulatory effect of a 14-membered ring macrolide antibiotic in cystic fibrosis patients
A. L. Pukhalsky, G. V. Shmarina, N. I. Kapranov, S. N. Kokarovtseva, N. J. Kashirskaja, T. V. Lubskaya (Moscow, Russia)
| |
Sputum culture findings and antipseudomonas antibodies in a single Italian Cystic Fibrosis Centre population
V. Lucidi, E. Fiscarelli, T. Salerno, L. Massenzi, S. Bella, G. Ricciotti, M. Castro (Rome, Italy)
| |
Long-term evaluation of the response to aggressive treatment at the first colonization of P.aeruginosa in cystic fibrosis (CF)
A. Escribano, B. Ferrándiz, D. Blanquer (Valencia, Spain)
| |
Comparative efficacy of different methods of ceftazidime administration in children with cystic fibrosis
S. M. Shatunov (Moscow, Russia)
| |
Impact of isolation of mycobacterium abscessus on lung transplantation in CF patients
K. Rueter, M. Hummel, R. Ewert, K. Magdorf, S. van Koenigsbruggen, A. Roth, E. Rietschel, U. Wahn, R. Hetzer, K. Paul (Berlin, Koeln, Germany)
| |
Revisiting FEV1 in cystic fibrosis
P. Camargos, I. Assis, F. Reis, N. Sulmonett, A. Carneiro (Belo Horizonte, Brazil)
| |
Exercise performance in children and young adults with cystic fibrosis
O. D. Roeksund, V. Helgheim, A. Insteboe, G. Fluge, G. Greve, T. Halvorsen, B. Skadberg (Bergen, Norway)
| |
Effects of DNase on pulmonary function and exercise capacity in cystic fibrosis (CF)
M. Barker, E. Franke, M. Boehle, C. Pfannenstiel, G. Heimann (Aachen, Germany)
| |
The epidemiology and invasive therapy of portal hypertension in cystic fibrosis
O. Efrati, A. Barak, Y. Bujanover, Y. Yahav (Ramat Gan, Israel)
| |